{"id":"placebo-plus-clinical-management","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL780","moleculeType":"Small molecule","molecularWeight":"393.35"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo plus clinical management","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T07:09:28.148807+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T07:09:34.490863+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo plus clinical management","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T07:09:35.213412+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL780/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T07:09:35.695850+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a control arm or comparator treatment rather than a pharmacologically active drug. It leverages placebo response—the therapeutic benefit derived from patient expectation and the ritual of treatment—combined with clinical management including counseling, monitoring, and supportive care. The mechanism relies on psychobiological pathways activated by the therapeutic context rather than specific molecular targets.","oneSentence":"Placebo plus clinical management provides psychological benefit through expectation effects combined with structured clinical support and therapeutic interaction.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:19.117Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T07:09:37.488028+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Substance use disorders (used as control/comparator in clinical trials)"}]},"trialDetails":[{"nctId":"NCT03375320","phase":"PHASE3","title":"Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-10-26","conditions":"Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm, Locally Advanced Digestive System Neuroendocrine Neoplasm","enrollment":298},{"nctId":"NCT05223036","phase":"PHASE2","title":"Testing Obeticholic Acid for Familial Adenomatous Polyposis","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2023-01-19","conditions":"Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma","enrollment":80},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT02443077","phase":"PHASE3","title":"Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-10-12","conditions":"Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type","enrollment":94},{"nctId":"NCT02965703","phase":"PHASE2","title":"Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-16","conditions":"Colorectal Adenoma, Colorectal Carcinoma","enrollment":81},{"nctId":"NCT06954987","phase":"PHASE2","title":"Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-17","conditions":"Acute Myeloid Leukemia","enrollment":244},{"nctId":"NCT05564390","phase":"PHASE2","title":"MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-18","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":2000},{"nctId":"NCT07133633","phase":"PHASE2","title":"A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-09-26","conditions":"Radiographic Axial Spondyloarthritis","enrollment":315},{"nctId":"NCT04858334","phase":"PHASE2","title":"APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-06-22","conditions":"Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma","enrollment":152},{"nctId":"NCT04172532","phase":"PHASE1, PHASE2","title":"Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-11","conditions":"Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8","enrollment":92},{"nctId":"NCT07353307","phase":"PHASE3","title":"A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2025-12-30","conditions":"Pain After Abdominal Surgery","enrollment":333},{"nctId":"NCT06063486","phase":"PHASE2","title":"Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2024-03-01","conditions":"Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome","enrollment":30},{"nctId":"NCT05111574","phase":"PHASE2","title":"Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-11","conditions":"Anal Melanoma, Bladder Melanoma, Cervical Melanoma","enrollment":101},{"nctId":"NCT06022822","phase":"PHASE2","title":"Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-09-12","conditions":"Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT05419011","phase":"PHASE2","title":"Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-08","conditions":"Colorectal Carcinoma, Colorectal Neoplasm, Lynch Syndrome","enrollment":186},{"nctId":"NCT06778122","phase":"NA","title":"In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors","status":"RECRUITING","sponsor":"University College, London","startDate":"2026-01-23","conditions":"Cancer Survivors, Cardiotoxicity, Cardiovascular Toxicity Induced by Antitumoral Drugs","enrollment":10},{"nctId":"NCT04939051","phase":"PHASE2","title":"Obeticholic Acid for Prevention in Barrett's Esophagus","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-01-03","conditions":"Barrett Esophagus, Esophageal Adenocarcinoma","enrollment":30},{"nctId":"NCT02968810","phase":"PHASE2","title":"Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-21","conditions":"Cirrhosis, Hepatocellular Carcinoma","enrollment":52},{"nctId":"NCT02193282","phase":"PHASE3","title":"Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-02-11","conditions":"Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7","enrollment":390},{"nctId":"NCT01841736","phase":"PHASE2","title":"Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-09-20","conditions":"Foregut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor, Metastatic Digestive System Neuroendocrine Tumor G1","enrollment":171},{"nctId":"NCT02194738","phase":"NA","title":"Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-09-26","conditions":"Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8","enrollment":8300},{"nctId":"NCT05500885","phase":"NA","title":"The Clinical Effectiveness of Pulsed Electromagnetic Field Therapy on the Management of Chronic Ankle Instability","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2023-01-02","conditions":"Chronic Ankle Instability","enrollment":62},{"nctId":"NCT07353671","phase":"PHASE2, PHASE3","title":"Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-01","conditions":"Radiation-induced Dermatitis","enrollment":60},{"nctId":"NCT05907239","phase":"NA","title":"Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin","status":"RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2023-04-20","conditions":"Temporomandibular Joint Disorders, Extracorporeal Shockwave Therapy","enrollment":100},{"nctId":"NCT06143956","phase":"PHASE2","title":"A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2023-11-17","conditions":"Obesity, Overweight","enrollment":1217},{"nctId":"NCT05416229","phase":"PHASE2","title":"Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder","status":"COMPLETED","sponsor":"Anders Fink-Jensen, MD, DMSci","startDate":"2023-09-01","conditions":"Alcohol Use Disorder","enrollment":60},{"nctId":"NCT02811055","phase":"PHASE2","title":"Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2017-07-13","conditions":"Type 2 Diabetes, Hypertension","enrollment":5},{"nctId":"NCT06210854","phase":"PHASE2","title":"Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+","status":"NOT_YET_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-05-01","conditions":"HPV Infection","enrollment":48},{"nctId":"NCT06672549","phase":"PHASE3","title":"A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-11-18","conditions":"Obesity, Overweight","enrollment":125},{"nctId":"NCT07489495","phase":"PHASE3","title":"A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)","status":"NOT_YET_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-04-17","conditions":"Carcinoma, Renal Cell","enrollment":758},{"nctId":"NCT07485842","phase":"PHASE4","title":"FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-04","conditions":"Chronic Endometritis","enrollment":300},{"nctId":"NCT06374693","phase":"NA","title":"Investigating the Tolerability and Feasibility of tVNS Following aSAH","status":"RECRUITING","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2024-04-17","conditions":"Subarachnoid Haemorrhage From Cerebral Aneurism Rupture","enrollment":30},{"nctId":"NCT07339631","phase":"PHASE1","title":"Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2026-03-01","conditions":"Low Back Pain, Paraspinal Muscle, CLBP - Chronic Low Back Pain","enrollment":40},{"nctId":"NCT06451120","phase":"PHASE2","title":"Platelet Rich Plasma Injections In Young And Old Human Subjects","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-06-01","conditions":"Osteoarthritis, Articular Cartilage, Musculoskeletal Disorders","enrollment":60},{"nctId":"NCT07482085","phase":"PHASE3","title":"Efavirenz for the Treatment of Creutzfeldt-Jakob Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03","conditions":"Creutzfeldt-Jakob Disease","enrollment":246},{"nctId":"NCT06732388","phase":"PHASE2","title":"Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-02-16","conditions":"Barrett Esophagus, Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8","enrollment":64},{"nctId":"NCT06795893","phase":"","title":"The Anifrolumab PRIM Program","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-07","conditions":"Systemic Lupus Erythematosus","enrollment":240},{"nctId":"NCT03304496","phase":"PHASE4","title":"Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.","status":"SUSPENDED","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2018-03-30","conditions":"Coronary Artery Disease","enrollment":1400},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT04615429","phase":"PHASE2","title":"Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS","status":"COMPLETED","sponsor":"Cristina Avendaño Solá","startDate":"2020-09-15","conditions":"Acute Respiratory Distress Syndrome, COVID-19 Pneumonia","enrollment":20},{"nctId":"NCT06962852","phase":"PHASE1, PHASE2","title":"A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-05-20","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT07472907","phase":"PHASE1, PHASE2","title":"A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations","status":"NOT_YET_RECRUITING","sponsor":"Cilcare SAS","startDate":"2026-08","conditions":"Cochlear Synaptopathy","enrollment":135},{"nctId":"NCT06659029","phase":"","title":"Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-07-01","conditions":"Systemic Lupus Erythematosus","enrollment":442},{"nctId":"NCT07473570","phase":"PHASE1","title":"A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2026-01-07","conditions":"Healthy Adults","enrollment":32},{"nctId":"NCT07424144","phase":"PHASE3","title":"An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps","status":"ENROLLING_BY_INVITATION","sponsor":"Sanofi","startDate":"2026-03-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":380},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT05476497","phase":"PHASE1","title":"Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Allergy Therapeutics","startDate":"2022-10-17","conditions":"Peanut Allergy","enrollment":46},{"nctId":"NCT07452744","phase":"NA","title":"Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Bioagile Therapeutics Pvt. Ltd.","startDate":"2024-08-13","conditions":"Non Alcholic Fatty Liver Disease","enrollment":170},{"nctId":"NCT07464431","phase":"PHASE4","title":"Evaluating the Clinical Effectiveness of Sodium Bicarbonate for Critically Ill Patients With Metabolic Acidosis and Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"Universität Münster","startDate":"2026-03","conditions":"Acute Kidney Injury, Metabolic Acidosis, Critical Illness","enrollment":660},{"nctId":"NCT07463378","phase":"PHASE1","title":"Study of LUT017 Gel to Improve Healing of Skin Wounds After Removal of Benign Lesions in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Antoni Ribas","startDate":"2026-04","conditions":"Wound Healing, Acute Skin Wounds","enrollment":9},{"nctId":"NCT05405361","phase":"PHASE2","title":"A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"argenx","startDate":"2023-01-18","conditions":"Multifocal Motor Neuropathy (MMN)","enrollment":51},{"nctId":"NCT06899815","phase":"PHASE1","title":"Preliminary Human Trials of F230 Tablets","status":"RECRUITING","sponsor":"Beijing Continent Pharmaceutical Co, Ltd.","startDate":"2025-05-15","conditions":"Pulmonary Hypertension","enrollment":136},{"nctId":"NCT07459959","phase":"PHASE1, PHASE2","title":"LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-06-01","conditions":"Alzheimer s Disease","enrollment":40},{"nctId":"NCT06059391","phase":"PHASE2","title":"CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-12","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia","enrollment":216},{"nctId":"NCT04134845","phase":"PHASE2, PHASE3","title":"A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-08-21","conditions":"Ventricular Tachycardia","enrollment":68},{"nctId":"NCT07460895","phase":"NA","title":"Effectiveness of Photobiomodulation for Myofascial Pain in Temporomandibular Disorders","status":"NOT_YET_RECRUITING","sponsor":"Federal University of Rio Grande do Sul","startDate":"2026-03-10","conditions":"Photobiomodulation, Temporomandibular Disorder (TMD), Myofacial Pain","enrollment":140},{"nctId":"NCT04872660","phase":"PHASE4","title":"Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET","status":"RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2021-06-15","conditions":"Infertility, Female","enrollment":800},{"nctId":"NCT07456852","phase":"PHASE1, PHASE2","title":"Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-03-31","conditions":"Malignant Digestive System Neoplasm","enrollment":60},{"nctId":"NCT07457632","phase":"PHASE2","title":"Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Diabetic Macular Edema (DME)","enrollment":69},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07456813","phase":"NA","title":"Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period","status":"NOT_YET_RECRUITING","sponsor":"Cuiling Feng","startDate":"2026-03-15","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":126},{"nctId":"NCT04958109","phase":"PHASE1","title":"Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-10-28","conditions":"Metabolic Diseases","enrollment":16},{"nctId":"NCT06485258","phase":"PHASE1","title":"CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2024-08-06","conditions":"Rotavirus Infections","enrollment":50},{"nctId":"NCT07042438","phase":"PHASE2","title":"Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-02-11","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma","enrollment":56},{"nctId":"NCT07450378","phase":"PHASE3","title":"QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2026-05","conditions":"Heterozygous Familial Hypercholesterolemia (HeFH)","enrollment":120},{"nctId":"NCT07445919","phase":"PHASE2","title":"A Clinical Study to Evaluate SM17 for Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"SinoMab BioScience Ltd","startDate":"2026-04-05","conditions":"Atopic Dermatitis","enrollment":200},{"nctId":"NCT06992427","phase":"PHASE3","title":"High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2025-06-05","conditions":"Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8","enrollment":228},{"nctId":"NCT06594068","phase":"PHASE4","title":"Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-16","conditions":"Systemic Lupus Erythematosus","enrollment":16},{"nctId":"NCT05184712","phase":"PHASE3","title":"Phase 3 Clinical Study of AK112 for NSCLC Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Akeso","startDate":"2022-01-25","conditions":"Non-Squamous Non-small Cell Lung Cancer","enrollment":322},{"nctId":"NCT07445815","phase":"PHASE2","title":"A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody","status":"NOT_YET_RECRUITING","sponsor":"Lanzhou Institute of Biological Products Co., Ltd","startDate":"2026-01-31","conditions":"Rabies (Healthy Volunteers)","enrollment":200},{"nctId":"NCT06722729","phase":"PHASE2","title":"A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"2024-12-16","conditions":"Parkinson Disease","enrollment":150},{"nctId":"NCT07015268","phase":"PHASE3","title":"A Clinical Study of KLH-2109 in Patients With Endometriosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"2025-06-09","conditions":"Endometriosis","enrollment":288},{"nctId":"NCT00343460","phase":"PHASE3","title":"APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2006-06","conditions":"Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":1428},{"nctId":"NCT07444086","phase":"PHASE3","title":"QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2026-03-05","conditions":"Primary Hypercholesterolemia or Mixed Hyperlipidemia","enrollment":510},{"nctId":"NCT07440069","phase":"PHASE4","title":"Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor","status":"RECRUITING","sponsor":"Universidad Nacional Autonoma de Honduras","startDate":"2026-02-15","conditions":"Labor Pain","enrollment":300},{"nctId":"NCT07421297","phase":"PHASE3","title":"A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia","status":"NOT_YET_RECRUITING","sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","startDate":"2026-04-01","conditions":"Non-familial Hypercholesterolemia and Mixed Hyperlipidemia","enrollment":760},{"nctId":"NCT07022678","phase":"PHASE3","title":"Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-08-08","conditions":"Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia","enrollment":556},{"nctId":"NCT07435961","phase":"NA","title":"Magnetotherapy in Carpal Tunnel Syndrome: Randomized Controlled Study","status":"NOT_YET_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2026-02-01","conditions":"Magnetotherapy, Carpal Tunnel Syndrome (CTS), Median Nerve Compression","enrollment":60},{"nctId":"NCT06686355","phase":"PHASE2","title":"The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula","status":"RECRUITING","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2024-11-20","conditions":"Sepsis Induced Myocardial Dysfunction","enrollment":80},{"nctId":"NCT07428681","phase":"PHASE4","title":"Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2027-03","conditions":"Delirium Confusional State","enrollment":260},{"nctId":"NCT07433413","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Sciencare Medical Industries Co., Ltd.","startDate":"2026-03-15","conditions":"Alcohol Use Disorder (AUD)","enrollment":240},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT06254183","phase":"PHASE4","title":"Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG)","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-12-01","conditions":"Acute Kidney Injury, Obesity (BMI > 35)","enrollment":90},{"nctId":"NCT07050134","phase":"NA","title":"A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque","status":"ENROLLING_BY_INVITATION","sponsor":"Junbo Ge","startDate":"2025-07-01","conditions":"Hypertriglyceridemia, Carotid Atherosclerotic Plaques","enrollment":40},{"nctId":"NCT07432893","phase":"NA","title":"Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts","status":"RECRUITING","sponsor":"Sarah Nabia","startDate":"2026-01-13","conditions":"Hypertension, Diabete Mellitus, Breathlessness","enrollment":672},{"nctId":"NCT07431775","phase":"","title":"Saphnelo Use in Females of Child-bearing Potential","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-10-01","conditions":"Systemic Lupus Erythematosus","enrollment":26000000},{"nctId":"NCT07198607","phase":"NA","title":"Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2024-03-04","conditions":"Chronic Rhinosinusitis Without Nasal Polyps, Chronic Rhinosinusitis (Diagnosis)","enrollment":100},{"nctId":"NCT07076498","phase":"PHASE1","title":"Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-12-01","conditions":"Glioma","enrollment":20},{"nctId":"NCT05577754","phase":"PHASE2","title":"Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-11-28","conditions":"Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)","enrollment":20},{"nctId":"NCT06855524","phase":"PHASE2","title":"Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-03-06","conditions":"Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm","enrollment":34},{"nctId":"NCT05354141","phase":"PHASE3","title":"Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2022-07-01","conditions":"Acute Respiratory Distress Syndrome, ARDS","enrollment":970},{"nctId":"NCT06070350","phase":"PHASE3","title":"Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children","status":"RECRUITING","sponsor":"Philip Spinella","startDate":"2024-11-01","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":1000},{"nctId":"NCT07426237","phase":"PHASE4","title":"Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Hospital Nossa Senhora da Conceicao","startDate":"2026-03-30","conditions":"Myocardial Protection","enrollment":60},{"nctId":"NCT06788587","phase":"PHASE2","title":"Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-07-18","conditions":"Methamphetamine Abuse, Methamphetamine-dependence, Addiction","enrollment":80},{"nctId":"NCT05303701","phase":"PHASE3","title":"GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)","status":"NOT_YET_RECRUITING","sponsor":"Samsung Pharmaceutical Co., Ltd.","startDate":"2027-07","conditions":"Moderate to Severe Alzheimer's Disease","enrollment":750},{"nctId":"NCT07176390","phase":"PHASE2","title":"A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-10-08","conditions":"Arthritis, Rheumatoid","enrollment":182},{"nctId":"NCT03540485","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis","status":"TERMINATED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2019-11-29","conditions":"Sclerosis, Multiple, Autoimmune Diseases of the Nervous System, Nervous System Diseases","enrollment":25},{"nctId":"NCT03295383","phase":"PHASE3","title":"Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2019-07-11","conditions":"Severe Forms of Mucous Membrane Pemphigoid","enrollment":130},{"nctId":"NCT07413055","phase":"PHASE3","title":"Dexamethasone (4 mg vs. 8 mg) for Pain Control in Dental Implant Surgery","status":"RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2026-02-05","conditions":"Postoperative Pain","enrollment":138},{"nctId":"NCT01432821","phase":"NA","title":"Blinking and Yawning in Epilepsy: The Role of Dopamine","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2011-09","conditions":"Idiopathic Generalized Epilepsy","enrollment":31}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL780"},"_approvalHistory":[],"publicationCount":52,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo and Clinical Management"],"phase":"marketed","status":"active","brandName":"Placebo plus clinical management","genericName":"Placebo plus clinical management","companyName":"Centre for Addiction and Mental Health","companyId":"centre-for-addiction-and-mental-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo plus clinical management provides psychological benefit through expectation effects combined with structured clinical support and therapeutic interaction. Used for Substance use disorders (used as control/comparator in clinical trials).","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T07:09:37.488028+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}